⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21449920 | 0.94 | — | — | |
| SCHEMBL13952415 | 0.64 | — | — | |
| SCHEMBL17572145 | 0.64 | — | — | |
| SCHEMBL11056207 | 0.62 | — | — | |
| SCHEMBL23138777 | 0.59 | — | — | |
| SCHEMBL19309481 | 0.59 | — | — | |
| SCHEMBL17049775 | 0.59 | — | — | |
| SCHEMBL19865540 | 0.59 | — | — | |
| SCHEMBL17326365 | 0.59 | — | — | |
| SCHEMBL19278168 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4390399-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DAIGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE | Uniwersytet Gdanski (PL) | 2024-06-26 | — | — | EP | disclosed |
| WO-2023193892-A1 | NUCLEIC ACID COMPOSITIONS COMPRISING AN INORGANIC POLYPHOSPHATE AND METHODS FOR PREPARING, STORING AND USING THE SAME | BioNTech SE (DE) | 2023-10-12 | — | — | WO | disclosed |
| EP-4257152-A2 | APELIN POLYPEPTIDES | Amgen Inc. (US) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023142450-A1 | DIAGNOSIS AND EARLY WARNING APPARATUS AND METHOD FOR CONDUCTIVITY OF HYDROGEN FUEL CELL ENGINE SYSTEM | 金龙联合汽车工业（苏州）有限公司 | 2023-08-03 | — | — | WO | disclosed |
| EP-4213270-A1 | ELECTRODE ASSEMBLY FOR SECONDARY BATTERY, AND SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2023-07-19 | — | — | EP | disclosed |
| EP-3870043-B1 | SKIN SODIUM MEASUREMENT USING BIOIMPEDANCE | FRESENIUS MEDICAL CARE HOLDINGS INC (US) | 2023-07-05 | — | — | EP | disclosed |
| WO-2023081854-A1 | AKT3 MODULATORS | GEORGIAMUNE LLC (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081812-A2 | AKT3 MODULATORS | GEORGIAMUNE LLC (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081845-A1 | AKT3 MODULATORS | GEORGIAMUNE LLC (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20230146956-A1 | MULTIMERIC OLIGONUCLEOTIDES WITH DIVIDED STRANDS | MPEG LA, L.L.C. | 2023-05-11 | — | — | US | disclosed |
| US-20110082369-A1 | METHODS AND APPARATUS FOR DISPLAYING ENHANCED IMAGING DATA ON A CLINICAL IMAGE | INTUITIVE SURGICAL, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| US-7897774-B2 | Cyclic compound having quinolylalkylthio group | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7807676-B2 | Diketo-Piperazine and Piperidine derivatives as antiviral agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-10-05 | — | — | US | disclosed |
| US-7807671-B2 | Diketo-piperazine and piperidine derivatives as antiviral agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-10-05 | — | — | US | disclosed |
| EP-2186814-A1 | SULFONYL-SUBSTITUTED CARBAPENEM COMPOUNDS | KBP Biosciences Co., Ltd. (CN) | 2010-05-19 | — | — | EP | disclosed |
| US-20080139572-A1 | DIKETO-PIPERAZINE AND PIPERIDINE DERIVATIVES AS ANTIVIRAL AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2008-06-12 | — | — | US | disclosed |
| US-20080021064-A1 | Novel cyclic compound having quinolylalkylthio group | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2008-01-24 | — | — | US | disclosed |
| US-20070281178-A1 | PDP filter having multi-layer thin film and method of manufacturing the same | SAMSUNG CORNING CO., LTD | 2007-12-06 | — | — | US | disclosed |
| US-20070249579-A1 | DIKETO-PIPERAZINE AND PIPERIDINE DERIVATIVES AS ANTIVIRAL AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-25 | — | — | US | disclosed |
| US-20070003535-A1 | Methods and compositions for derepression of IAP-inhibited caspase | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2007-01-04 | — | — | US | disclosed |